<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220910055929N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-24</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of kinesiotape on performance of patients over 50 years old with intermittent claudication</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of kinesiotape on gait performance and fatigue in patients over 50 years old with intermittent claudication referred to Sina hospital: A single-blind randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65805</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The distribution of volunteers was done by random block method with blocks of two, three, four and six (15 places in total) and one group was named with the symbol A and the other group with the symbol B. Using the random allocation table of the "Random Allocation Software 2.0", the assignment of candidates to the positions within the blocks was done. The sample allocation ratio will be 1:1 and volunteers will be placed in two groups receiving kinesiotape therapy (A) or ineffective kinesiotype (B). Then, based on the obtained blocks and according to the order of the allocation sequence, one of two types of intervention is performed, Blinding description: In this study, the patient and the researcher are fully aware of the type of treatment received by each patient. In the following, the collected data is provided to the analyst in raw form, but information about whether each of these data belongs to the treatment group or the control group is not provided to the analyst and in other words, in this study, the analyst will be blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Peripheral Arterial Disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, to attach the kinesiotape, the patient is placed on the bed in prone position and the leg will be in dorsiflexion. Then the spot is disinfected with alcohol and two strips are attached from the origin of the gastrocnemius muscle in two directions, one along the medial part of this muscle and the other along the lateral part of this muscle towards the final insertion point of this muscle on the heel bone. Intervention 2: Control group: In the control group, the patient will be placed in a prone position and the foot will be placed in a neutral position (without flexion or extension) and after disinfecting the area with alcohol, a kinesiotape will be attached to the superior part of the gastrocnemius horizontally, almost perpendicular to this muscle.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The present study has been registered as a proposal for the thesis of sports medicine residency. The dissertation resulting from this proposal including participants' data (all data), study protocol, statistical analysis and study report (including all variables) will be provided to Tehran University of Medical Sciences and Sports Medicine Department. It should be noted that after the dissertation is approved, an article containing all the items mentioned will be published in one of the journals relevant to the research topic. It should be noted that access to detailed data that were not published in the final report or article, requires communication with the researcher in charge of the study.

When:
The present study started on 23/9/2022 and for all stages until the submission of the dissertation, a period of two years is predicted. The data obtained from this research will be presented in the form of an article after the dissertation is approved (end of 2 years) for publication. Access to the detailed data that were not published in the final report or article will be possible after the publication of the article through direct contact with the researcher in charge of the study.

To whom:
The data obtained from this research will be available to all applicants and there will be no restrictions.

Conditions:
There is no restriction on the use, dissemination or processing of the data in this study, provided that correspondence is sent via email or other means to the researcher in charge of the study and the necessary permission is issued by the researcher in charge.

Where to obtain:
To access the information in this study, the applicant can contact the researcher in charge of this study by e-mail or telephone.

How to obtain:
The license to use the information is issued to the applicant as soon as possible after receiving and viewing the e-mail or making a phone call, and then the requested information will immediately sent to the applicant via e-mail.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoomeh Salahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Sports Medicine, Imam Khomeini Hospital Complex, Gharib Street, Keshavarz Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۹۷۳۳۱۴۱</zip>
        <telephone>+98 21 6658 1637</telephone>
        <email>m-salahi@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Abolhasani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini St., Sina Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1136746911</zip>
        <telephone>+98 21 6634 8500</telephone>
        <email>dr_m_abolhasani@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with symptomatic peripheral arterial disease
Age over 50 years
Intermittent claudication stage 2 and 3 in the Rutherford classification system
Ankle-Brachial Index &lt; 0.9</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having critical organ ischemia
Pain while resting
Amputated limb
Having a respiratory disease
Contraindications for kinesiotape application such as: deep vein thrombosis, kidney failure, congestive heart disease, infection, wound, cancer and sensitivity to kinesiotape
The patient's unwillingness to cooperate</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I73.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Peripheral vascular disease, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, to attach the kinesiotape, the patient is placed on the bed in prone position and the leg will be in dorsiflexion. Then the spot is disinfected with alcohol and two strips are attached from the origin of the gastrocnemius muscle in two directions, one along the medial part of this muscle and the other along the lateral part of this muscle towards the final insertion point of this muscle on the heel bone.</i_keyword>
      <i_keyword>Control group: In the control group, the patient will be placed in a prone position and the foot will be placed in a neutral position (without flexion or extension) and after disinfecting the area with alcohol, a kinesiotape will be attached to the superior part of the gastrocnemius horizontally, almost perpendicular to this muscle.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>6 Minutes Walk Test. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: The patient is asked to walk a distance of 30 meters as many times as possible and at the end of the sixth minute, the distance traveled is measured.</prim_outcome>
      <prim_outcome>Claudication Pain Distance. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: It is measured based on the distance covered until the onset of pain on the treadmill.</prim_outcome>
      <prim_outcome>Claudication Pain Time. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: It is measured based on the time elapsed until the onset of pain on the treadmill.</prim_outcome>
      <prim_outcome>Maximal Walking Distance. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: It is measured based on the distance covered up to the endurance limit on the treadmill.</prim_outcome>
      <prim_outcome>Maximal Walking Time. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: Based on the time the patient has walked on the treadmill to the limit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>American Orthopedic Foot and Ankle Score (AOFAS) assessment: The American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score is among the most commonly used instruments for measuring the outcome of treatment in patients who sustained a complex ankle or hindfoot injury. It combines a clinician-reported and a patient-reported part. Timepoint: Before the intervention, immediately and 72 hours after the intervention. Method of measurement: The American Orthopedic Foot and Ankle Score (AOFAS) has a four-point Likert scale. The total score is divided into three sub-headings, which include pain, function and alignment. A maximum score of 100 is obtained by combining patient-reported pain and function scores and physician-assessed gait (in terms of alignment).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-31</approval_date>
        <contact_name>Research Ethics Committee of Sina Hospital - Tehran University of Medical Sciences</contact_name>
        <contact_address>Imam Khomeini St., Sina Hospital, Research Vice-Chancellor Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
